THE ONLY NONINVASIVE SOLUTION THAT OPENS A WINDOW INTO PATIENTS’ HEMODYNAMIC AND FLUID STATUS
YOUR WINDOW TO THE HEART
NICaS® is an innovative, non-invasive & cost-effective system, that simplifies the challenging task of treating and monitoring hemodynamic and fluid management problems.
OUR VISION
Our goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Haemodialysis, ICU/CCU, Neonatal, and treatment of infectious diseases.
The NI-MEDICAL NICaS® System provides a much needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings.
OUR SOLUTIONS
Monitoring patients with heart diseases, that at risk of stroke, heart failure or other cardiac problems, enables physicians to provide better supervision and treatment for their patients in a broad variety of clinical applications.
As common methods that measure parameters such as stroke volume and cardiac output, require invasive procedure such as the insertion of a catheter, the use of measurement of these parameters in diagnosing heart patients is very limited.
NI Medical’s non-invasive system, uniquely designed to enable physicians measure various settings of cardiac parameters, such as ICUs, hospitals, clinics or even at the patient’s home.
NICaS® technology was developed for improving medical outcomes, chronic or acute, in various clinical applications including: heart failure and cardiac status, preeclampsya management, hypertension and hypotension control, hemodialysis and dialysis, CRT optimization, hemodynamic monitoring during anesthesia and stroke volume management.
CLINICAL APPLICATION
THE CHALLENGE
OUR SOLUTION
HEART FAILURE
Using NICaS for management of HF patients reduces Hospital
Readmission Rate by over 90%
HYPERTENSION
Only 50% of Hypertensive patients in the US are
under control
Customers who are using NICaS for management of hypertension have reported control rate of over 90%
Preeclampsia
Preeclampsia and eclampsia can lead to increased risks of significant maternal and perinatal adverse outcomes, including death.
NICaS is designed to assist physicians in finding the exact cause of hypertension, thus significantly reducing these risks.
DIALYSIS
NICaS can provide each
patient with a complete hemodynamic
profile enabling to set
more accurate dry weight
and treatment strategy
and therefore reduce unnecessary
hospitalizations
ICU/ICCU
COVID 19
Due to the pandemic, many healthcare systems are overwhelmed and unable to provide optimal respiratory treatment to their patients. In addition, over 20% of COVID 19 patients develop cardiac injury, on top of patients with preexisting cardiac conditions
NICaS can provide accurate and continuous cardiorespiratory
information to optimize the treatment
for patients with ARDS. While limiting
the exposure of medical teams,
it also helps reduce risk of infection.
Pharma Clinical trials
NICaS provides a cost-effective and easy
to use system. With its highly accurate,
sensitive and reproducible information,
NiCaS helps speed up the drug development process.
NICaS® modular and compact design makes it accessible and easy to use in various medical settings:
Cardiac ICUs (CICU), General ICUs, Internal Wards, ERs, ORs, CHF and Hypertension clinics, Dialysis, Nursing Facilities, Private Clinics, and even at the patient’s home
Easy setup
Connect NICaS® to any device (tablet, laptop, desktop), with an easy and quick installation process.
Simple operation
With NICaS® There’s No need to shave or undress the patients. Only two sensors are required for the system opertation.
Report
Flexible and easy to read.
Helps treating physicians prioritize
hemodynamic and fluid parameters
Frequently Asked Questions
NI Medical’s revolutionary innovation based on a non-invasive system. One uniquely designed to enable physicians measure various settings of cardiac parameters.
NICaS is highly accurate and has been validated in more than 1200 catheterizations with reproducible results compared to the thermodilution method. Agreement between NICaS cardiac output and thermodilution cardiac output is within boundaries of FDA guidelines of bio-equivalence.
NICaS cardiac output is applicable for non-invasive assessment of cardiac function.
The NICaS has been shown to be very useful in optimization of hypertension therapy, chronic heart failure patients care, Dialysis patients management, OBGYN, Drug titration and more.
SOME OF OUR REGULATORY
APPROVALS / CLEARANCES
LOCATIONS & DISTRIBUTORS
NI Medical is represented in many countries across North and South America, Europe and Asia Pacific. In event we have no distributor or partner in the country you are looking for, please contact us.
THE ONLY NON-INVASIVE SOLUTION THAT OPENS A CLEAR WINDOW INTO PATIENTS’ HEMODYNAMIC AND FLUID STATUS
YOUR WINDOW TO THE HEART
NICaS® is an innovative, non-invasive & cost-effective system, that simplifies the challenging task of treating and monitoring hemodynamic and fluid management problems.
Watch NICaS Intro:
OUR VISION
Our goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Haemodialysis, ICU/CCU, Neonatal, and treatment of infectious diseases.
The NI-MEDICAL NICaS® System provides a much needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings.
OUR SOLUTIONS
Monitoring patients with heart diseases, that at risk of stroke, heart failure or other cardiac problems, enables physicians to provide better supervision and treatment for their patients in a broad variety of clinical applications.
As common methods that measure parameters such as stroke volume and cardiac output, require invasive procedure such as the insertion of a catheter, the use of measurement of these parameters in diagnosing heart patients is very limited.
NI Medical’s non-invasive system, uniquely designed to enable physicians measure various settings of cardiac parameters, such as ICUs, hospitals, clinics or even at the patient’s home.
NICaS® technology was developed for improving medical outcomes, chronic or acute, in various clinical applications including: heart failure and cardiac status, preeclampsya management, hypertension and hypotension control, hemodialysis and dialysis, CRT optimization, hemodynamic monitoring during anesthesia and stroke volume management.
HEART FAILURE
THE CHALLENGE:
Average readmission rate for
Patient with HF is 30%
OUR SOLUTION:
Using NICaS for management of HF patients reduces Hospital
Readmission rate by over 90%
HYPERTENSION
THE CHALLENGE:
Only 50% of Hypertensive patients
in the US are under control
OUR SOLUTION:
Preeclampsia
THE CHALLENGE:
OUR SOLUTION:
NICaS is designed to assist physicians in finding the exact cause of hypertension, thus significantly reducing these risks.
DIALYSIS
THE CHALLENGE:
Although crucial for proper patient treatment, the dry weight and hemodynamic profile of patients are estimated rather than measured. This results in sub-optimal treatment and a high percentage of hospitalizations
OUR SOLUTION:
NICaS can provide each
patient with a complete hemodynamic profile enabling to set more accurate dry weight and treatment strategy
and therefore reduce unnecessary hospitalizations
ICU/ICCU
THE CHALLENGE:
While Hemodynamic Information is crucial for Patient management in the ICU only this data is only available for 20-30%
OUR SOLUTION:
COVID 19
THE CHALLENGE:
Due to the pandemic many healthcare systems are being overwhelmed and are unable to provide optimal respiratory treatment to their patients, in addition over 20% of COVID 19 patients develop cardiac injury (this is in addition to the patient with pre-existing cardiac conditions)
OUR SOLUTION:
NICaS can provide an accurate continuous cardiorespiratory information to optimise the treatment for patient with ARDS, while limiting the exposure of medical team and thus risk of infection
Pharma Clinical trials
THE CHALLENGE:
Many drug developers are struggling to evaluate the compounds for cardiac efficacy and safety, due to the high cost and reproducibility limitation of the current methods such as Echocardiography and Thermodilution
OUR SOLUTION:
NICaS provides cost effective easy to use highly accurate, sensitive and reproducible hemodynamic information allowing to speed up the drug development process
NICaS® modular and compact design makes it accessible and easy to use in various medical settings:
Cardiac ICUs (CICU), General ICUs, Internal Wards, ERs, ORs, CHF and Hypertension clinics, Dialysis, Nursing Facilities, Private Clinics, and even at the patient’s home
Easy setup
Connect NICaS® to any device (tablet, laptop, desktop), with an easy and quick installation process.
Simple operation
With NICaS® There’s No need to shave or undress the patients. Only two sensors are required for the system opertation.
Report
Frequently Asked Questions
NI Medical’s revolutionary innovation based on a non-invasive system. One uniquely designed to enable physicians measure various settings of cardiac parameters.
NICaS is highly accurate and has been validated in more than 1200 catheterizations with reproducible results compared to the thermodilution method. Agreement between NICaS cardiac output and thermodilution cardiac output is within boundaries of FDA guidelines of bio-equivalence.
NICaS cardiac output is applicable for non-invasive assessment of cardiac function.
The NICaS has been shown to be very useful in optimization of hypertension therapy, chronic heart failure patients care, Dialysis patients management, OBGYN, Drug titration and more.
SOME OF OUR Regulatory Approvals / Clearances:
LOCATIONS & DISTRIBUTORS
NI Medical is represented in many countries across North and South America, Europe and Asia Pacific. In event we have no distributor or partner in the country you are looking for, please contact us.